Lafayette Investments’s CVS Health CVS Stock Holding History

Lafayette Investments’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,650	Closed	-$530K	–	146
2024 Q1	$530K	Sell	6,650 -400	-6%	-$30.6K	0.12%	79
2023 Q4	$557K	Sell	7,050 -450	-6%	-$32K	0.14%	79
2023 Q3	$524K	Sell	7,500 -250	-3%	-$17.7K	0.14%	79
2023 Q2	$536K	Sell	7,750 -200	-3%	-$14.2K	0.14%	77
2023 Q1	$591K	Buy	7,950 +2,650	+50%	+$222K	0.16%	73
2022 Q4	$494K	Hold	5,300	–	–	0.14%	79
2022 Q3	$505K	Sell	5,300 -500	-9%	-$49.5K	0.16%	73
2022 Q2	$537K	Hold	5,800	–	–	0.16%	74
2022 Q1	$587K	Sell	5,800 -50	-0.9%	-$5.25K	0.15%	78
2021 Q4	$603K	Sell	5,850 -1,050	-15%	-$97K	0.15%	76
2021 Q3	$586K	Hold	6,900	–	–	0.16%	74
2021 Q2	$576K	Buy	+6,900	New	+$565K	0.16%	77

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Lafayette Investments's CVS Position: Q2 2024 in Review

Lafayette Investments sold out of CVS Health (CVS) in Q2 2024, closing a stake of 6,650 shares — an estimated $530K sold.

Lafayette Investments first reported a position in CVS in Q2 2021 and held it in 12 quarters. The position peaked at $603K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Lafayette Investments reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Lafayette Investments sold 6,650 CVS Health shares in Q2 2024, an estimated $530K.
Lafayette Investments first reported a position in CVS Health in Q2 2021 and held it in 12 quarters.
Lafayette Investments's CVS Health position peaked at $603K in Q4 2021.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Lafayette Investments's 13F filing for Q2 2024, filed 31 Jul 2024.